insights_auto
Why is DRUG up 4.87%?
Dive Deeperchevron_right
DRUG:CNSX
Bright Minds Biosciences Inc
CA$77.10
arrow_upward
+4.87%(+3.58) 1D
Oct 9, 4:00:00 PM GMT-4 · CAD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DRUG...
Open
CA$76.13
High
CA$77.76
Low
CA$76.13
Mkt. cap
760.52M
Avg. vol.
865.00
Volume
400.00
52-wk high
CA$170.00
52-wk low
CA$68.02
EPS
-CA$2.90
No. of employees
26
Open
CA$76.13
High
CA$77.76
Low
CA$76.13
Mkt. cap
760.52M
Avg. vol.
865.00
Volume
400.00
52-wk high
CA$170.00
52-wk low
CA$68.02
EPS
-CA$2.90
No. of employees
26
News stories
From web sources and news partners
Quartz
·
6 minutes ago
Wall Street opens mixed ahead of bank earnings, CPI data
TradingView
·
49 minutes ago
Dow tries to build a base, but resistance looms ahead
ChartMill
·
1 hour ago
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
24/7 Wall St.
·
8 minutes ago
Stock Market Today: S&P 500 Futures Pause Near Record Highs as Oil Rises Ahead of Bank Earnings
Profile
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HTâ‚‚ receptor agonists for potential medical use.
It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens.
The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
About Bright Minds Biosciences Inc